Archive for November, 2010

J&J Recalls Tylenol Cold Drugs Over Alcohol Labeling

Johnson & Johnson, the world’s largest health-products company, recalled 9.3 million bottles of Tylenol cold treatments because they don’t disclose the medicine’s alcohol content on the front label. The recall affects three types of Tylenol Multi-Symptom liquid cold medicine sold in the U.S. by the McNeil Consumer Healthcare unit, J&J spokeswoman Bonnie Jacobs said today in a telephone interview.

Click here to read more…

Popular painkillers taken off the market

Although still in wide use more than a half-century after introduction, Darvon and Darvocet and their generic counterparts are easily replaceable, pain management experts said Friday after the Food and Drug Administration asked that the popular painkillers be removed from the U.S. marketplace. The FDA’s decision, based on data showing a risk of serious heart rhythm abnormalities, caps years of controversy about the dangerous side effects of Darvon — known generically as propoxyphene — which was first approved by regulators in 1957.

Click here to read more…

J&J Unit Recalls Batches Of Cancer Drug Velcade In Europe, Japan

Johnson & Johnson (JNJ) has recalled more than 200,000 vials of cancer drug Velcade in Europe, Japan and Malaysia due to reports of visible particles in the drug that were caused by the manufacturing process. The U.K. Medicines and Healthcare products Regulatory Agency issued a notice Thursday saying J&J’s Janssen-Cilag unit was recalling all remaining stock of six batches of the drug as a precaution, following five reports of the particles. The batches were distributed between January and June.

Click here to read more…

Rare Treatment Is Reported to Cure AIDS Patient

Doctors in Berlin are reporting that they cured a man of AIDS by giving him transplanted blood stem cells from a person naturally resistant to the virus.The patient, a 42-year-old American resident in Germany, also has leukemia, which justified the high risk of a stem-cell transplant. Such transplants require wiping out a patient’s immune system, including bone marrow, with radiation and drugs; 10 to 30 percent of those getting them die.

Click here to read more…


Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 434 other followers

Contact Us:

Hissey Kientz, LLP

9442 Capital of Texas Hwy N.

Arboretum Plaza One, Suite 400

Austin, Texas 78759

Toll-free: (866) 275-4454

Facsimile: (512) 320-9101

Email: info@hkllp.com

Sponsored By:

Hissey Kientz, LLP (Austin, TX)

Attorney Michael Hissey is responsible for the content of this website.